Get the Stockscreener App
5.00
1.01%
0.05
After Hours:
4.99
-0.010
-0.20%
Achieve Life Sciences Inc stock is traded at $5.00, with a volume of 100.01K.
It is up +1.01% in the last 24 hours and up +16.82% over the past month.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$4.95
Open:
$4.9
24h Volume:
100.01K
Relative Volume:
0.84
Market Cap:
$171.71M
Revenue:
-
Net Income/Loss:
$-29.82M
P/E Ratio:
-1.6077
EPS:
-3.11
Net Cash Flow:
$-24.50M
1W Performance:
-0.40%
1M Performance:
+16.82%
6M Performance:
+13.90%
1Y Performance:
+34.77%
1-Day Range:
$4.90
$5.01
1-Week Range:
$4.87
$5.28
52-Week Range:
$3.03
$5.98
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
Achieve Life Sciences Inc Stock (ACHV) Latest News
Jones Trading maintains $20 target on Achieve Life Sciences stock By Investing.com - Investing.com UK
Achieve Life Sciences Announces Completion of Enrollment in - GlobeNewswire
Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting - The Manila Times
Commonwealth Alternative Care Aims High for Fall Community Engagement - The Manila Times
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products - StreetInsider.com
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products - AccessWire
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products - Big News Network
2024-10-10 | CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products | OTCPK:CBDL | Press Release - Stockhouse Publishing
Smoking Cessation and Nicotine Addiction Market Expected - openPR
Prendio-BioProcure Launches PrendioPay: Enabling Life Science Companies to Achieve Operational Excellence with a Complete Procure-to-Pay Solution - Yahoo Finance
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Where are the Opportunities in (ACHV) - Stock Traders Daily
Europe's Pneumococcal Vaccine Market Size Set to Achieve 2.9 Billion By 2032, Growing at 5.8% CAGR As Revea... - WhaTech
Kezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus Nephritis - BioSpace
GetFueled Emerges from Stealth with New Life Sciences-Focused Proposition and Rebranding - Newswire Today
Achieve Life Sciences falls as FDA seeks more data on lead product - MSN
JonesTrading Initiates Coverage of Achieve Life Sciences (ACHV) with Buy Recommendation - MSN
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs - The Manila Times
Achieve Life Sciences Strengthens Leadership with - GlobeNewswire
Poland's Zabka eyes $1.7 billion IPO in potential boost for Warsaw bourse - Yahoo Finance UK
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs - StockTitan
Achieve, INmune, Lenz gain on bullish initiations from Raymond James - MSN
American Century Companies Inc. Purchases 26,010 Shares of Centrais Elétricas Brasileiras S.A. – Eletrobrás (NYSE:EBR) - Defense World
CVI Holdings LLC Cuts Stock Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
CVI Holdings LLC Cuts Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat
Achieve, INmune, Lenz stocks win bullish view from RayJay - Seeking Alpha
Achieve Life Sciences (NASDAQ:ACHV) Research Coverage Started at Raymond James - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Coverage Initiated at Raymond James - MarketBeat
Raymond James Initiates Coverage of Achieve Life Sciences (ACHV) with Strong Buy Recommendation - MSN
Global Nicotine Replacement Therapy Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2030 | DelveInsight - 新浪香港
Global Nicotine Replacement Therapy Market is Predicted to - GlobeNewswire
Where Asbury Automotive Gr Stands With Analysts - Benzinga
Chimeric announces new collaboration with Achieve Clinics - Biotech Dispatch
EKF Diagnostics (LON:EKF) Shares Cross Above Two Hundred Day Moving Average of $28.68 - Defense World
Apple Inc. (NASDAQ:AAPL) Position Decreased by Atlas Brown Inc. - Defense World
Flex Ltd. (NASDAQ:FLEX) Shares Purchased by Mount Yale Investment Advisors LLC - Defense World
CompleCure, AGC Biologics Partner To Develop Advanced Anti-Cancer Therapy - Contract Pharma
CompleCure Partners with AGC Biologics’ Chiba Site to Develop Advanced Anti-Cancer Therapeutic Using Pioneering AMDC Technology - AccessWire
AGC Biologics and CompleCure Collaborate on Innovative Breast Cancer Treatment - Vancity Buzz
Multibagger Stock: This small cap stock rockets 18710% in 11 years, turns ₹1 lakh into ₹2 crore | Stock Market News - Mint
Achieve Life Sciences Is All Fired UpStock Soars Over 70% - RTTNews
Agilent completes acquisition of biologics CDMO BIOVECTRA - Investing.com India
Agilent Completes Acquisition of BIOVECTRA – Company Announcement - Financial Times
Polyol Sweetener Market Set to Achieve USD 8.2 Billion Valuation by 2034 - Market Research Blog
Sofinnova Investments Inc. Has $6.53 Million Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat
Carica Papaya Seed Oil Market Trends: Expected to Achieve USD 408.6M by 2032 with a 5.4% CAGR - Future Market Insights
Smoking Cessation and Nicotine Addiction Market Insights 2034 - openPR
Smoking Cessation Treatment Market Size was ~USD 1800 Million in 2022, estimated DelveInsight - Barchart
Veterinary Hematology Analyzers Market Size to Achieve US$ - GlobeNewswire
Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business - PR Newswire
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019 - BioSpace
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Achieve Life Sciences Inc Stock (ACHV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JACOBS CINDY | President & CMO |
Apr 19 '24 |
Option Exercise |
0.00 |
16,250 |
0 |
34,511 |
| Stewart Richard Alistair | Executive Chairman |
Apr 19 '24 |
Option Exercise |
0.00 |
22,500 |
0 |
61,001 |
| Bencich John | CEO |
Apr 19 '24 |
Option Exercise |
0.00 |
25,000 |
0 |
101,724 |
| Stewart Richard Alistair | Executive Chairman |
Mar 04 '24 |
Buy |
4.58 |
10,000 |
45,850 |
38,501 |
| Bencich John | CEO |
Mar 04 '24 |
Buy |
4.58 |
10,000 |
45,850 |
76,724 |
0.76%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):